BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

May 21, 2024

https://www.globenewswire.com/news-release/2024/05/21/2885441/0/en/BioXcel-Therapeutics-Announces-Oral-and-Poster-Presentations-at-the-2024-American-Society-of-Clinical-Psychopharmacology-ASCP-Annual-Meeting.html

NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer of Neuroscience, will deliver oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. The meeting will take place May 28 to 31, 2024 in Miami Beach, FL. 

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.